Tretinoin (All-Trans Retinoic Acid)

1 Products
Well-established Evidence
Approved drug US status
Ingredient Type
Retinoids Most common in

The full tretinoin (all-trans retinoic acid) guide

Everything sold as a retinoid is trying to become this molecule.

Retinol, retinaldehyde, retinyl esters and the various encapsulated derivatives all have to be converted inside the skin cell — one step, two steps, sometimes three — before they can bind anything. Tretinoin arrives already converted. It is retinoic acid itself, which is why its clinical file is the deepest in topical dermatology and why none of that evidence legitimately transfers to the bottle of retinol on the shelf.

Where the evidence stands, by concern

Evidence for an ingredient is not one grade — it differs concern by concern. Each row below was researched separately against regulatory approvals, clinical guidelines, and trials our team opened and verified; the band and dots rank how central tretinoin (all-trans retinoic acid) is to treating that concern, from first-line therapy down to supportive care, at treatment-level doses and vehicles. A product's own grade weighs its actual formula.

Researched, not established: Acne Scarring, Large Pores, Melasma. We looked at each of these and the current evidence does not clear our bar for a treatment standing — that is a finding, not a gap in our research.

How it's regulated in the US

FDA does not classify ingredients — it classifies products, by what they are sold to do. The same molecule can be a drug active in one product and a cosmetic ingredient in the next, and only the claim on the label decides which. What follows is a statement about that legal standing, not about whether it works — the evidence question is answered separately above.

Approved drug Tretinoin is prescription-only in the US and has been since 1971. No amount of it is a cosmetic ingredient, and no OTC monograph covers it — which is precisely why the retinol aisle exists.

  • acne FDA-approved 0.025 to 0.1 percent cream and gel

    Approved by FDA under a New Drug Application

    Permitted label wording “For the topical treatment of acne vulgaris”

    RETIN-A- tretinoin cream / RETIN-A- tretinoin gel

  • photoaging FDA-approved 0.02 to 0.05 percent emollient cream

    Approved by FDA under a New Drug Application

    Permitted label wording “For the mitigation of fine facial wrinkles, mottled hyperpigmentation and tactile roughness of facial skin, as an adjunct to a comprehensive skin care and sun avoidance programme”

    The photoaging indication is written as an adjunct to sun avoidance, not as a standalone anti-ageing claim — a distinction the marketing around retinoids routinely loses.

    REFISSA- tretinoin cream (Tretinoin Cream, USP (Emollient) 0.05%) — INDICATIONS AND USAGE

Tretinoin is prescription-only and carries FDA approval for acne and, as the 0.02% and 0.05% emollient creams, for fine facial wrinkles, mottled hyperpigmentation and tactile roughness of photodamaged skin. It is named in the 2024 AAD acne guidelines as a topical retinoid, and its comedolytic effect on the microcomedo is the single best-established action of the class. For photoaging the evidence runs from a 1988 JAMA double-blind vehicle-controlled trial through a 1993 NEJM paper demonstrating restored collagen formation in photodamaged skin, to a 2025 systematic review and meta-analysis of randomized trials. Pigment evidence is real but weaker and claim-specific: post-inflammatory hyperpigmentation and solar lentigines each have their own supporting trials at 0.1%, and both sit at an earlier stage of confidence than the acne and wrinkle data.

How it works

Tretinoin binds directly to retinoic acid receptors — RAR alpha, beta and gamma — inside the keratinocyte nucleus, where the receptor complex docks onto DNA and rewrites which genes the cell is transcribing. From that single point of entry, two fairly different clinical stories unfold. In acne, the rewritten program normalizes how follicular keratinocytes mature and stick together. The microcomedo, the invisible plug of retained cells that precedes every blackhead and every inflamed lesion, stops forming and existing ones dissolve. This is comedolysis, and it is why a retinoid prevents the next month's breakouts rather than just drying the current one. In photoaged skin, the action runs through collagen. Ultraviolet exposure switches on activator protein-1, which drives matrix metalloproteinases that chew through dermal collagen; tretinoin applied beforehand blocks that pathway. At the same time it pushes fibroblasts to make new collagen, measurable as increased type I procollagen in treated skin. Degradation down, synthesis up — over months, that arithmetic shows up as smoother texture and softened fine lines. The cost of engaging these pathways is retinization: two to twelve weeks of dryness, flaking and sensitivity while the epidermis adjusts. It is the treatment working on its target, not a reaction to it, and it settles.

Key benefits
  • Dissolves the microcomedo that precedes blackheads and inflamed lesions
  • Blocks UV-driven collagen breakdown while stimulating new type I procollagen
  • FDA-approved for fine wrinkles, mottled pigment and rough photoaged texture
  • Named in the AAD acne guidelines as a first-line topical retinoid
  • Decades of randomized trial data across multiple distinct endpoints
  • Works on both comedonal and inflammatory acne in the same application
Concentration & usage

Acne strengths run 0.025% to 0.1% in cream, gel, lotion and microsphere gel, applied once nightly. The photoaging presentations are 0.02% and 0.05% emollient cream, with 0.05% the strength most used in wrinkle studies. Higher is not automatically better — there is no verified head-to-head gradient showing a monotonic dose-response on wrinkle endpoints, and irritation rises reliably with concentration in a way efficacy does not. Vehicle matters as much as percentage: microsphere and polymerized formulations release the drug more gradually and are measurably better tolerated at equal strength, and emollient creams suit dry or mature skin better than alcohol-based gels. All of it is prescription-only in the US; anything sold over the counter as a 'retinoid' is a different molecule with different evidence.

Who it's for & who should be cautious

Who it's for

Anyone with persistent comedonal or inflammatory acne who has not responded to over-the-counter actives has a clear case for a prescription retinoid, and tretinoin is the reference member of that class. It is equally the evidence-backed choice for someone whose priority is photoaging — fine lines, mottled pigment, rough texture from years of sun — provided they are prepared to commit for six months rather than six weeks. People who have used OTC retinol consistently and found the results underwhelming are often simply under-dosed on the actual active, and stand to gain most from the switch.

Who should be cautious

Pregnancy is a hard stop. Tretinoin is a retinoid, oral retinoids are established teratogens, and while topical absorption is low the drug is contraindicated in pregnancy and should be discontinued by anyone pregnant, trying to conceive, or breastfeeding pending a conversation with a clinician. Active eczema, rosacea or a genuinely compromised barrier will usually flare before they improve, and those skins need the barrier repaired first. Anyone unwilling or unable to use daily sunscreen should not start — tretinoin thins the stratum corneum initially and raises photosensitivity. Concurrent chemical peels, ablative laser or prescription exfoliants need dermatological coordination, not improvisation.

Pairs with & conflicts
Myths & facts

Myth: Retinol is just tretinoin you can buy without a prescription.

Reality: They sit at different points on the same conversion pathway. Retinol has to be oxidized inside the cell to retinaldehyde and then to retinoic acid before anything binds a receptor, and each step loses material. Tretinoin is the end product. That difference is mechanistic, not marketing, and it is precisely why tretinoin's trial evidence cannot be borrowed by an OTC retinol product — a point worth remembering when a serum's marketing cites retinoid research it did not generate.

Myth: You have to push through severe peeling for tretinoin to work.

Reality: Irritation is a side effect of the delivery, not a measure of the effect. Retinization is common and settles, but sustained raw, stinging skin means the barrier is losing and the routine needs adjusting — less often, a buffered application over moisturizer, a lower strength, or an emollient vehicle. Consistency over months is what produces results; enduring damage is not part of the mechanism.

Myth: Tretinoin thins the skin.

Reality: It thins the stratum corneum, the dead outer layer, in the early weeks — which is where the photosensitivity and the flaking come from. The living dermis moves in the opposite direction: tretinoin blocks the matrix metalloproteinases that degrade collagen and increases type I procollagen production, which was demonstrated directly in photodamaged human skin. Over time, treated skin has more dermal collagen, not less.

Frequently asked questions

How long before tretinoin actually shows results?

For acne, expect six to twelve weeks, often with an initial worsening as existing microcomedones surface. For wrinkles and photoaging, the meaningful data come from trials running six to twelve months — collagen remodelling is slow. Anyone judging tretinoin at the four-week mark is measuring the retinization phase, not the treatment.

Is the purging phase real or just irritation?

Both exist and they look different. Purging appears where you normally break out, as lesions that were already forming underneath arrive faster, and it settles within about six to eight weeks. Irritation appears anywhere the product goes, as burning, tightness and redness without new lesions. Purging is worth riding out; irritation means dialling back frequency.

Can tretinoin fade dark spots and melasma?

It has trial support at 0.1% for post-inflammatory hyperpigmentation and for solar lentigines, both at an earlier stage of evidence than its acne and wrinkle data. For melasma specifically, tretinoin's main established role is as one third of the FDA-approved triple combination cream with hydroquinone and fluocinolone, which outperforms hydroquinone alone.

Should I stop tretinoin in summer?

No — but sunscreen becomes non-negotiable. Tretinoin increases photosensitivity, and its own photoaging benefit is partly wasted if UV keeps activating the collagen-degrading pathways it is blocking. Apply at night, since the molecule is light-unstable, and use daily broad-spectrum protection year-round rather than treating it as a seasonal add-on.

Can I use benzoyl peroxide with tretinoin?

Not in the same application. Benzoyl peroxide is an oxidizer and can degrade tretinoin on the skin, which is why the conventional advice is benzoyl peroxide in the morning and tretinoin at night. Some newer stabilized and microencapsulated formulations are designed to tolerate the combination — the product's own instructions are the authority.

What makes prescription tretinoin different from an OTC retinaldehyde or granactive retinoid?

The number of conversion steps standing between the molecule and the receptor. Retinaldehyde is one step away and is the strongest of the OTC options; retinyl esters are furthest. All of them lose material at each conversion, so the receptor-level dose is lower and less predictable than a measured percentage of retinoic acid applied directly.

Sources